Atrial septal defect
|Atrial septal defect|
Illustration of an atrial septal defect.
|Classification and external resources|
Atrial septal defect (ASD) is a congenital heart defect in which blood flows between the atria (upper chambers) of the heart. Normally, the atria are separated by a dividing wall, the interatrial septum. If this septum is defective or absent, then oxygen-rich blood can flow directly from the left side of the heart to mix with the oxygen-poor blood in the right side of the heart, or vice versa. This can lead to lower-than-normal oxygen levels in the arterial blood that supplies the brain, organs, and tissues. However, an ASD may not produce noticeable signs or symptoms, especially if the defect is small.
A "shunt" is the presence of a net flow of blood through the defect, either from left to right or right to left. The amount of shunting present, if any, determines the hemodynamic significance of the ASD. A "right-to-left-shunt" typically poses the more dangerous scenario.
During development of the fetus, the interatrial septum develops to separate the left and right atria. However, a hole in the septum called the foramen ovale, allows blood from the right atrium to enter the left atrium during fetal development. This opening allows blood to bypass the nonfunctional fetal lungs while the fetus obtains its oxygen from the placenta. A layer of tissue called the septum primum acts as a valve over the foramen ovale during fetal development. After birth, the pressure in the right side of the heart drops as the lungs open and begin working, causing the foramen ovale to close entirely. In approximately 25% of adults, the foramen ovale does not entirely seal. In these cases, any elevation of the pressure in the pulmonary circulatory system (due to pulmonary hypertension, temporarily while coughing, etc.) can cause the foramen ovale to remain open. This is known as a patent foramen ovale (PFO), a type of atrial septal defect.
- 1 Cause
- 2 Types
- 3 Mechanisms
- 4 Diagnosis
- 5 Treatment
- 6 Complications
- 7 Epidemiology
- 8 References
- 9 External links
- Down syndrome – patients with Down Syndrome have higher rates of ASDs, especially a particular type that involves the ventricular wall. As many as one half of Down Syndrome patients have some type of septal defect.
- Ebstein's anomaly - About 50% of individuals with Ebstein anomaly have an associated shunt between the right and left atria, either an atrial septal defect or a patent foramen ovale.
- Fetal alcohol syndrome – about one in four patients with fetal alcohol syndrome has either an ASD or a ventricular septal defect.
- Holt–Oram syndrome – Both the osteium secundum and osteum primum types of ASD are associated with Holt–Oram syndrome
- Lutembacher's syndrome – the presence of a congenital ASD along with acquired mitral stenosis.
There are many types of atrial septal defects. They are differentiated from each other by whether they involve other structures of the heart and how they are formed during the developmental process during early fetal development.
Ostium secundum atrial septal defect
The ostium secundum atrial septal defect is the most common type of atrial septal defect, and comprises 6–10% of all congenital heart diseases.
The secundum atrial septal defect usually arises from an enlarged foramen ovale, inadequate growth of the septum secundum, or excessive absorption of the septum primum. Ten to twenty percent of individuals with ostium secundum ASDs also have mitral valve prolapse.
Most individuals with an uncorrected secundum ASD do not have significant symptoms through early adulthood. More than 70 percent develop symptoms by about 40 years of age. Symptoms are typically decreased exercise tolerance, easy fatigueability, palpitations, and syncope.
While pulmonary hypertension is unusual before 20 years of age, it is seen in 50 percent of individuals above the age of 40. Progression to Eisenmenger's syndrome occurs in 5 to 10 percent of individuals late in the disease process.
Patent foramen ovale
A patent foramen ovale (PFO) is a small channel that has some hemodynamic consequence; it is a remnant of the fetal foramen ovale (/ , , /), which normally closes at birth. In medical use, the term "patent" (//) means open or unobstructed. In approximately 25% of people, the foramen ovale fails to close properly, leaving them with a PFO or at least with what some physicians classify as a "pro-PFO", which is a PFO that is normally closed but can open under increased blood pressure. On echocardiography, there may not be any shunting of blood noted except when the patient coughs.
Clinically, PFO is linked to stroke, sleep apnea, migraine with aura, and decompression sickness. There is no established cause for a foramen ovale to remain open instead of closing naturally, but heredity and genetics may play a role.
The mechanism by which a PFO may play a role in stroke is called paradoxical embolism. In the case of PFO, a blood clot from the venous circulatory system is able to pass from the right atrium directly into the left atrium via the PFO, rather than being filtered by the lungs, and thereupon into systemic circulation toward the brain. PFO is common in patients with atrial septal aneurysms (ASA) which are also linked to cryptogenic (i.e. of unknown cause) strokes.
PFO is more prevalent in patients with cryptogenic stroke than in patients with a stroke of known cause. While PFO is present in only 25 percent in the general population, the probability of someone having a PFO increases to about 40 to 50 percent in patients who have had a cryptogenic stroke. Statistically speaking, this is particularly true for patients who have a stroke before the age of 55.
PFO is not treated in the absence of other symptoms, and there is no consensus on treatment of PFO even in the presence of TIA or stroke. Moreover, there is no "gold standard" treatment option. However, treatments for PFO include surgical closure and percutaneous device closure, as well as medical therapies such as anticoagulant therapy, and antiplatelet agents.
Research studies of the efficacy of surgical closure treatments versus medical therapies of PFOs in preventing the recurrence of strokes have been conducted; the results are mixed, although “as-treated” and “per-protocol” analyses were positive for closure devices.
As an outcome of data from the 10-year RESPECT trial—and breaking a long history of inconclusiveness for the viability of successful prevention of stroke via PFO closure—as of May 2016 a majority of FDA advisors are reported to be supportive of an Amplatzer PFO closure device for stroke prevention. However, "the entire strategy has proved to be one of the most polarizing topics in cardiovascular medicine, often pitting cardiologists in favor of closure against neurologists dead set against it". PFO closure devices may be implanted via catheter-based procedures, and using a variety of closure devices, though no devices are as yet approved by the FDA specifically for the purpose of PFO closure.
There is debate within the neurology and cardiology communities about the role of a PFO in cryptogenic neurologic events such as strokes and transient ischemia attacks (TIAs) without any other potential cause. Some data suggest that PFOs may be involved in the pathogenesis of some migraine headaches. Several clinical trials are currently underway to investigate the role of PFO in these clinical situations.
Ostium primum atrial septal defect
A defect in the ostium primum is occasionally classified as an atrial septal defect, but it is more commonly classified as an atrioventricular septal defect. Ostium primum defects are less common than ostium secundum defects. This is type of defect is usually associated with Down Syndrome.
Sinus venosus atrial septal defect
A sinus venosus ASD that involves the superior vena cava makes up 2 to 3% of all interatrial communication. It is located at the junction of the superior vena cava and the right atrium. It is frequently associated with anomalous drainage of the right-sided pulmonary veins into the right atrium (instead of the normal drainage of the pulmonary veins into the left atrium).
Common or single atrium
Mixed atrial septal defect
The inter atrial septum can be divided into 5 septal zones. If the defect involves 2 or more of the 5 septal zones, then the defect is termed a mixed atrial septal defect.
In unaffected individuals, the chambers of the left side of the heart are under higher pressure than the chambers of the right side of the heart. This is because the left ventricle has to produce enough pressure to pump blood throughout the entire body, while the right ventricle needs only to produce enough pressure to pump blood to the lungs.
In the case of a large ASD (>9mm), which may result in a clinically remarkable left-to-right shunt, blood will shunt from the left atrium to the right atrium. This extra blood from the left atrium may cause a volume overload of both the right atrium and the right ventricle. If untreated, this condition can result in enlargement of the right side of the heart and ultimately heart failure.
Any process that increases the pressure in the left ventricle can cause worsening of the left-to-right shunt. This includes hypertension, which increases the pressure that the left ventricle has to generate in order to open the aortic valve during ventricular systole, and coronary artery disease which increases the stiffness of the left ventricle, thereby increasing the filling pressure of the left ventricle during ventricular diastole. The left-to-right shunt increases the filling pressure of the right heart (preload) and forces the right ventricle to pump out more blood than the left ventricle. This constant overloading of the right side of the heart will cause an overload of the entire pulmonary vasculature. Eventually, pulmonary hypertension may develop.
The pulmonary hypertension will cause the right ventricle to face increased afterload. The right ventricle will be forced to generate higher pressures to try to overcome the pulmonary hypertension. This may lead to right ventricular failure (dilatation and decreased systolic function of the right ventricle).
If the ASD is left uncorrected, the pulmonary hypertension progresses and the pressure in the right side of the heart will become greater than the left side of the heart. This reversal of the pressure gradient across the ASD causes the shunt to reverse; a right-to-left shunt will exist. This phenomenon is known as Eisenmenger's syndrome. Once right-to-left shunting occurs, a portion of the oxygen-poor blood will get shunted to the left side of the heart and ejected to the peripheral vascular system. This will cause signs of cyanosis.
Heart of human embryo of about thirty-five days
blood flow to right atria from superior vena cava & inferior vena cava
right atria to right ventrical
right ventrical to pulmonary artery
pulmonary arteries to lungs
lungs to left atria via pulmonary vein
left atria to left ventricals and some flow to right atria also
causes overload of right heart
right side heart failure
Some individuals with an ASD will have undergone surgical correction of their ASD during childhood. The development of signs and symptoms due to an ASD are related to the size of the intracardiac shunt. Individuals with a larger shunt tend to present with symptoms at a younger age.
Adults with an uncorrected ASD will present with symptoms of dyspnea on exertion (shortness of breath with minimal exercise), congestive heart failure, or cerebrovascular accident (stroke). They may be noted on routine testing to have an abnormal chest x-ray or an abnormal ECG and may have atrial fibrillation. If the ASD causes a left-to-right shunt, the pulmonary vasculature in both lungs may appear dilated on chest x-ray, due to the increase in pulmonary blood flow.
The physical findings in an adult with an ASD include those related directly to the intracardiac shunt, and those that are secondary to the right heart failure that may be present in these individuals.
Upon auscultation of the heart sounds, there may be a systolic ejection murmur that is attributed to the pulmonic valve. This is due to the increased flow of blood through the pulmonic valve rather than any structural abnormality of the valve leaflets.
In unaffected individuals, there are respiratory variations in the splitting of the second heart sound (S2). During respiratory inspiration, the negative intrathoracic pressure causes increased blood return into the right side of the heart. The increased blood volume in the right ventricle causes the pulmonic valve to stay open longer during ventricular systole. This causes a normal delay in the P2 component of S2. During expiration, the positive intrathoracic pressure causes decreased blood return to the right side of the heart. The reduced volume in the right ventricle allows the pulmonic valve to close earlier at the end of ventricular systole, causing P2 to occur earlier.
In individuals with an ASD, there is a fixed splitting of S2. The reason that there is a fixed splitting of the second heart sound is that the extra blood return during inspiration gets equalized between the left and right atrium due to the communication that exists between the atria in individuals with ASD.
The right ventricle can be thought of as continuously overloaded because of the left to right shunt, producing a widely split S2. Because the atria are linked via the atrial septal defect, inspiration produces no net pressure change between them, and has no effect on the splitting of S2. Thus, S2 is split to the same degree during inspiration as expiration, and is said to be “fixed”.
In transthoracic echocardiography, an atrial septal defect may be seen on color flow imaging as a jet of blood from the left atrium to the right atrium.
If agitated saline is injected into a peripheral vein during echocardiography, small air bubbles can be seen on echocardiographic imaging. It may be possible to see bubbles travel across an ASD either at rest or during a cough. (Bubbles will only flow from right atrium to left atrium if the RA pressure is greater than LA).
Because better visualization of the atria is achieved with transesophageal echocardiography, this test may be performed in individuals with a suspected ASD which is not visualized on transthoracic imaging.
Newer techniques to visualize these defects involve intracardiac imaging with special catheters that are typically placed in the venous system and advanced to the level of the heart. This type of imaging is becoming more common and involves only mild sedation for the patient typically.
If the individual has adequate echocardiographic windows, it is possible to use the echocardiogram to measure the cardiac output of the left ventricle and the right ventricle independently. In this way, it is possible to estimate the shunt fraction using echocardiography.
Transcranial doppler bubble study
The ECG findings in atrial septal defect vary with the type of defect the individual has. Individuals with atrial septal defects may have a prolonged PR interval (a first degree heart block). The prolongation of the PR interval is probably due to the enlargement of the atria that is common in ASDs and the increased distance due to the defect itself. Both of these can cause an increased distance of internodal conduction from the SA node to the AV node.
In addition to the PR prolongation, individuals with a primum ASD have a left axis deviation of the QRS complex while those with a secundum ASD have a right axis deviation of the QRS complex. Individuals with a sinus venosus ASD exhibit a left axis deviation of the P wave (not the QRS complex).
A common finding in the ECG is the presence of incomplete right bundle branch block. The presence of a right bundle branch block is so characteristic that if it is absent, the diagnosis of ASD should be reconsidered.
Once someone is found to have an atrial septal defect, a determination of whether it should be corrected has to be made.
Surgical mortality due to closure of an ASD is lowest when the procedure is performed prior to the development of significant pulmonary hypertension. The lowest mortality rates are achieved in individuals with a pulmonary artery systolic pressure of less than 40 mmHg.
If Eisenmenger's syndrome has occurred, there is significant risk of mortality regardless of the method of closure of the ASD. In individuals who have developed Eisenmenger's syndrome, the pressure in the right ventricle has raised high enough to reverse the shunt in the atria. If the ASD is then closed, the afterload that the right ventricle has to act against has suddenly increased. This may cause immediate right ventricular failure, since it may not be able to pump the blood against the pulmonary hypertension.
Closure of an ASD in individuals under age 25 has been shown to have a low risk of complications, and individuals have a normal lifespan (comparable to a healthy age-matched population). Closure of an ASD in individuals between the ages of 25 and 40 who are asymptomatic but have a clinically significant shunt is controversial. Those that perform the procedure believe that they are preventing long-term deterioration in cardiac function and preventing the progression of pulmonary hypertension.
Methods of closure of an ASD include surgical closure and percutaneous closure.
Although invasive, surgical closure is particularly beneficial because additional drug therapy is not needed. This is considered to be the gold standard to prevent PFO and paradoxical embolism.
Percutaneous device closure involves the passage of a catheter into the heart through the femoral vein guided by fluoroscopy and echocardiography. An example of a percutaneous device is the Cardia PFO occluder which has discs that can expand to a variety of diameters at the end of the catheter. The catheter is placed in the right femoral vein and guided into the right atria. The catheter is guided through the atrial septal wall and one disc (left atrial) is opened and pulled into place. Once this occurs, the other disc (right atrial) is opened in place and the device is inserted into the septal wall. This type of PFO closure is more effective than drug or other medical therapies for decreasing the risk of future thromboembolism.
Drug therapy can be used to minimize risk of thromboembolism and stroke in PFO. Anticoagulants, such as warfarin, are commonly used to reduce blood clotting, whereas antiplatelet agents, such as aspirin, to reduce platelet aggregation and thrombosis.
Evaluation prior to correction
Prior to correction of an ASD, an evaluation is made of the severity of the individual's pulmonary hypertension (If present at all) and whether it is reversible (Closure of an ASD may be recommended for prevention purposes, to avoid such a complication in the first place. Pulmonary hypertension is not always present in adults that are diagnosed with an ASD in adulthood).
If pulmonary hypertension is present, the evaluation may include a right heart catheterization. This involves placing a catheter in the venous system of the heart and measuring pressures and oxygen saturations in the SVC, IVC, right atrium, right ventricle, pulmonary artery, and in the wedge position. Individuals with a pulmonary vascular resistance (PVR) of less than 7 wood units show regression of symptoms (including NYHA functional class). On the other hand, individuals with a PVR of greater than 15 wood units have increased mortality associated with closure of the ASD.
If the pulmonary arterial pressure is more than 2/3 the systemic systolic pressure, there should be a net left-to-right shunt of at least 1.5:1 or evidence of reversibility of the shunt when given pulmonary artery vasodilators prior to surgery. (If Eisenmenger's physiology has set in, it must be proven that the right-to-left shunt is reversible with pulmonary artery vasodilators prior to surgery.)
Until the early 1990s, surgery was the usual method for closing all ASDs. Now, thanks to medical advances, doctors can use catheter procedures to close secundum ASDs, the most common type of ASD. During the procedure, the doctor inserts a catheter (a thin, flexible tube) into a vein in the groin (upper thigh) and threads it to the heart's septum. The catheter has a tiny umbrella-like device folded up inside it. When the catheter reaches the septum, the device is pushed out of the catheter and positioned so that it plugs the hole between the atria. The device is secured in place and the catheter is withdrawn from the body. Within 6 months, normal tissue grows in and over the device. There is no need to replace the closure device throughout the patient's life. Doctors often use echocardiography (echo) or transesophageal echo (TEE) as well as angiography to guide them in threading the catheter to the heart and closing the defect. TEE is a special type of echo that takes pictures of the heart through the esophagus (the passage leading from the mouth to the stomach). Catheter procedures are much easier on patients than surgery because they involve only a needle puncture in the skin where the catheter is inserted. This means that recovery is faster and easier. The outlook for patients having this procedure is excellent. Closures are successful in more than 9 out of 10 patients, with no significant leakage. Rarely, a defect is too large for catheter closure and surgery is needed.
Surgical ASD closure
Surgical closure of an ASD involves opening up at least one atrium and closing the defect with a patch under direct visualization.
Percutaneous ASD closure
Percutaneous closure of an ASD is currently only indicated for the closure of secundum ASDs with a sufficient rim of tissue around the septal defect so that the closure device does not impinge upon the SVC, IVC, or the tricuspid or mitral valves. The Amplatzer Septal Occluder (ASO) is commonly used to close ASDs. The ASO consists of two self-expandable round discs connected to each other with a 4 mm waist, made up of 0.004–0.005´´ Nitinol wire mesh filled with Dacron fabric. Implantation of the device is relatively easy. The prevalence of residual defect is low. The disadvantages are a thick profile of the device and concern related to a large amount of nitinol (a nickel-titanium compound) in the device and consequent potential for nickel toxicity.
Percutaneous closure is the method of choice in most centres.
Due to the communication between the atria that occurs in ASDs, disease entities or complications from the condition, are possible. Patients with an uncorrected atrial septal defects may be at increased risk for developing a cardiac arrhythmia, as well as more frequent respiratory infections.
ASDs, and particularly PFOs, are a predisposing risk factor for decompression sickness in divers because a proportion of venous blood carrying inert gases, such as helium or nitrogen does not pass through the lungs. The only way to release the excess inert gases from the body is to pass the blood carrying the inert gases through the lungs to be exhaled. If some of the inert gas-laden blood passes through the PFO, it avoids the lungs and the inert gas is more likely to form large bubbles in the arterial blood stream causing decompression sickness.
If a net flow of blood exists from the left atrium to the right atrium, called a left-to-right shunt, then there is an increase in the blood flow through the lungs. Initially, this increased blood flow is asymptomatic, but if it persists, the pulmonary blood vessels may stiffen, causing pulmonary hypertension. The pulmonary hypertension increases the pressures in the right side of the heart, leading to the reversal of the shunt into a right-to-left shunt. Once the reversal of the shunt occurs, and the blood begins flowing in the opposite direction through the ASD, that is called Eisenmenger's syndrome. The syndrome is a rare and late complication of an ASD.
Venous thrombus (clots in the veins) are quite common. Embolizations (dislodgement of thrombi) normally go to the lung and cause pulmonary emboli. In an individual with ASD, these emboli can potentially enter the arterial system. This can cause any phenomenon that is attributed to acute loss of blood to a portion of the body, including cerebrovascular accident (stroke), infarction of the spleen or intestines, or even a distal extremity (i.e., finger or toe).
This is known as a paradoxical embolus because the clot material paradoxically enters the arterial system instead of going to the lungs.
Some recent research has suggested that a proportion of cases of migraine may be caused by patent foramen ovale. While the exact mechanism remains unclear, closure of a PFO can reduce symptoms in certain cases. This remains controversial. 20% of the general population have a PFO, which for the most part, is asymptomatic. 20% of the female population have migraines. And, the placebo effect in migraine typically averages around 40%. The high frequency of these facts makes statistically significant relationships between PFO and migraine difficult (i.e., the relationship may just be chance or coincidence). In a large randomized controlled trial the higher prevalence of patent foramen ovale in migraine patients was confirmed, but migraine headache cessation was not more prevalent in the group of migraine patients that underwent closure of their patent foramen ovale.
As a group, atrial septal defects are detected in 1 child per 1500 live births. PFO are quite common (appearing in 10–20% of adults) but asymptomatic and therefore undiagnosed. ASDs make up 30 to 40% of all congenital heart diseases that are seen in adults.
The ostium secundum atrial septal defect accounts for 7% of all congenital heart lesions. This lesion shows a female preponderance, with a male:female ratio of 1:2.
- "Atrial Septal Defect Information - The Mount Sinai Hospital".
- Tamparo, Carl (2011). Fifth Edition: Diseases of the Human Body. Philadelphia, PA: F.A. Davis Company. pg.111>
- Kumar, Vinay (2007). Robbins Basic Pathology (8th ed.). Philadelphia: Saunders/Elsevier. p. 384. ISBN 1416029737.
- "Ostium Secundum Atrial Septal Defects". WebMD. Medscape. Retrieved 5 November 2012.
- Vis, JC; Duffels, MG; Winter, MM; Weijerman, ME; Cobben, JM; Huisman, SA; Mulder, BJ (May 2009). "Down syndrome: a cardiovascular perspective.". Journal of intellectual disability research : JIDR 53 (5): 419–25. doi:10.1111/j.1365-2788.2009.01158.x. PMID 19228275.
- Cherry, C; DeBord, S; Moustapha-Nadler, N (June 2009). "Ebstein's anomaly: a complex congenital heart defect.". AORN Journal 89 (6): 1098–110; quiz 1111–4. doi:10.1016/j.aorn.2009.03.003. PMID 19606562.
- p.119 Jaypee Brothers, First Edition 2014, ISBN 978-93-5152-140-2.
- Burd, L; Deal, E; Rios, R; Adickes, E; Wynne, J; Klug, MG (July–Aug 2007). "Congenital heart defects and fetal alcohol spectrum disorders.". Congenital heart disease 2 (4): 250–5. doi:10.1111/j.1747-0803.2007.00105.x. PMID 18377476. Check date values in:
- Bossert, T; Walther, T; Gummert, J; Hubald, R; Kostelka, M; Mohr, FW (October 2002). "Cardiac malformations associated with the Holt–Oram syndrome – report on a family and review of the literature.". The Thoracic and cardiovascular surgeon 50 (5): 312–4. doi:10.1055/s-2002-34573. PMID 12375192. Retrieved 7 November 2012.
- Goldman 2011, pp. 400–401
- Leachman R, Cokkinos D, Cooley D (1976). "Association of ostium secundum atrial septal defects with mitral valve prolapse". Am J Cardiol 38 (2): 167–9. doi:10.1016/0002-9149(76)90144-2. PMID 952260.
- "foramen". Merriam-Webster Dictionary., "ovale". Merriam-Webster Dictionary..
- "patent". Merriam-Webster Dictionary.
- "patent". Medical Dictionary. TheFreeDictionary.com. September 1, 2014. Retrieved 2015-03-26.
- 2013, Boston Childrens Hospital. "Patent Foramen Ovale Symptoms & Causes - Boston Children's Hospital".
- "Patent Foramen Ovale - Texas Heart Institute Heart Information Center".
- "Patent Foramen Ovale (PFO)".
- Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, Felberg R, Herrmann H, Kar S, Landzberg M, Raizner A, Wechsler L (2012). "Closure or medical therapy for cryptogenic stroke with patent foramen ovale". The New England Journal of Medicine 366 (11): 991–9. doi:10.1056/NEJMoa1009639. PMID 22417252.
- Freixa X, Arzamendi D, Tzikas A, Noble S, Basmadjian A, Garceau P, Ibrahim R (2014). "Cardiac procedures to prevent stroke: patent foramen ovale closure/left atrial appendage occlusion". The Canadian Journal of Cardiology 30 (1): 87–95. doi:10.1016/j.cjca.2013.11.008. PMID 24365193.
- Homma, Shunichi; Sacco, Ralph L; Di Tullio, Marco R; Sciacca, Robert R; Mohr, JP (2002). "Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study". Circulation 105 (22): 2625–31. doi:10.1161/01.CIR.0000017498.88393.44. PMID 12045168.
- "Patent Foramen Ovale (PFO)".
- "Patent Foramen Ovale Treatment & Management: Medical Care, Surgical Care, Complications" – via eMedicine.
- "Treatment of atrial septal abnormalities (PFO, ASD, and ASA) for prevention of stroke in adults".
- "Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke", John D. Carroll, M.D., Jeffrey L. Saver, M.D., et al, The New England Journal of Medicine, March 21, 2013, http://www.nejm.org/doi/pdf/10.1056/NEJMoa1301440
- Bang, Oh Young; Lee, Mi Ji; Ryoo, Sookyung; Kim, Suk Jae; Kim, Ji Won (30 September 2015). "Patent Foramen Ovale and Stroke–Current Status" 17 (3): 229–237. doi:10.5853/jos.2015.17.3.229. PMC 4635723. PMID 26437990.
- Medicine, Cleveland Clinic Journal of. "Patent foramen ovale and the risk of cryptogenic stroke : Cleveland Clinic Journal of Medicine".
- "Clinical Trials Registry - Internet Stroke Center".
- "RESPECT Confirms Long-term Safety, Efficacy of PFO Closure for Recurrent Stroke - Thursday - TCTMD".
- "Majority of FDA Advisors Give Green Light to Amplatzer PFO Closure Device for Stroke - Daily News - TCTMD".
- "How is a Patent Foramen Ovale (PFO) Closed Using a Catheter-based Procedure?". Cleveland Clinic. Retrieved 20 July 2016.
- Brauser, Deborah (16 October 2015). "RESPECT 10-Year Data Strengthens Case for PFO Closure After Cryptogenic Stroke". Medscape. Retrieved 20 July 2016.
- McCandless RT, Arrington CB, Nielsen DC, Bale JF, Minich LL (2011). "Patent foramen ovale in children with migraine headaches". The Journal of Pediatrics 159 (2): 243–7.e1. doi:10.1016/j.jpeds.2011.01.062. PMID 21450305.
- "Atrial Septal Defect Types – Mayo Clinic". Archived from the original on 28 September 2007. Retrieved 2007-10-14.
- Fix, James D.; Dudek, Ronald W. (1998). Embryology. Baltimore: Williams & Wilkins. p. 52. ISBN 0-683-30272-8.
- Skelley, Tao Le, Vikas Bhushan, Nathan William. First aid for the USMLE step 2 CK (8th ed.). New York: McGraw–Hill Medical. p. 357. ISBN 978-0-07-176137-6.
- Davia J, Cheitlin M, Bedynek J (1973). "Sinus venosus atrial septal defect: analysis of fifty cases". Am Heart J 85 (2): 177–85. doi:10.1016/0002-8703(73)90458-4. PMID 4569755.
- Valdes-Cruz, L. M.; Cayre, R. O. (1998). Echocardiographic diagnosis of congenital heart disease. Philadelphia.
- John, J; Abrol, S; Sadiq, A; Shani, J (Jul 26, 2011). "Mixed atrial septal defect coexisting ostium secundum and sinus venosus atrial septal defect.". Journal of the American College of Cardiology 58 (5): e9. doi:10.1016/j.jacc.2010.11.077. PMID 21777739. Retrieved 17 June 2012.
- Goldman 2011, pp. 270
- Glen, S.; J. Douglas. (1995). "Transcranial doppler monitoring. (letter to editor)". South Pacific Underwater Medicine Society Journal 25 (2). ISSN 0813-1988. OCLC 16986801. Retrieved 2008-04-06.
- Clark E, Kugler J (1982). "Preoperative secundum atrial septal defect with coexisting sinus node and atrioventricular node dysfunction". Circulation 65 (5): 976–80. doi:10.1161/01.CIR.65.5.976. PMID 7074763.
- Schneider, B. and Bauer, R. (2005). “Is Surgical Closure of Patent Foramen Ovale the Gold Standard for Treating Interatrial Shunts? An Echocardiographic Follow-up Study”. Journal of the American Society of Echocardiography 18(12):1385–1391.
- Spies, C., Strasheim, R., Timmermanns, I., Schraeder, R. (2006). “Patent foramen ovale closure in patients with cryptogenic thrombo-embolic events using the Cardia PFO occlude”. European Heart Journal (27): 365–371.
- Bjørnstad P (2006). "Is interventional closure the current treatment of choice for selected patients with deficient atrial septation?". Cardiol Young 16 (1): 3–10. doi:10.1017/S1047951105002027. PMID 16454871.
- Lier H, Schroeder S, Hering R (2004). "Patent foramen ovale: an underrated risk for divers?". Dtsch Med Wochenschr 129 (1–2): 27–30. doi:10.1055/s-2004-812652. PMID 14703578.
- Saary M, Gray G (2001). "A review of the relationship between patent foramen ovale and type II decompression sickness". Aviat Space Environ Med 72 (12): 1113–20. PMID 11763113.
- Adams H (2004). "Patent foramen ovale: paradoxical embolism and paradoxical data". Mayo Clin Proc 79 (1): 15–20. doi:10.4065/79.1.15. PMID 14708944.
- Azarbal B, Tobis J, Suh W, Chan V, Dao C, Gaster R (2005). "Association of interatrial shunts and migraine headaches: impact of transcatheter closure". J Am Coll Cardiol 45 (4): 489–92. doi:10.1016/j.jacc.2004.09.075. PMID 15708691.
- Dowson, Andrew; Mullen, MJ; Peatfield, R; Muir, K; Khan, AA; Wells, C; Lipscombe, SL; Rees, T; De Giovanni, JV; Morrison, WL; Hildick-Smith, D; Elrington, G; Hillis, WS; Malik, IS; Rickards, A (18 March 2008). "Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache.". Circulation 117 (11): 1397–404. doi:10.1161/CIRCULATIONAHA.107.727271. PMID 18316488.
- Kaplan S (1993). "Congenital heart disease in adolescents and adults. Natural and postoperative history across age groups". Cardiol Clin 11 (4): 543–56. PMID 8252558.
- Feldt R, Avasthey P, Yoshimasu F, Kurland L, Titus J (1971). "Incidence of congenital heart disease in children born to residents of Olmsted County, Minnesota, 1950–1969". Mayo Clin Proc 46 (12): 794–9. PMID 5128021.
This article incorporates public domain material from the United States Department of Health and Human Services document "National Heart, Lung, and Blood Institute".
- Goldman, Lee (2011). Goldman's Cecil Medicine (24th ed.). Philadelphia: Elsevier Saunders. pp. 270, 400–401. ISBN 1437727883.